Content about FDAPhase

June 16, 2010
Clinical trial for Merck KGaA's cancer vaccine continues

A division of German drug maker Merck KGaA has resumed its clinical trial of a...

June 13, 2010
Gilead patent for Ranexa challenged by Lupin

Indian generic drug maker Lupin is challenging a Gilead Sciences patent for a drug that...

June 13, 2010
Teva's investment in Andromeda will fund diabetes treatment

Teva Pharmaceutical Industries has invested $11.9 million in Andromeda Biotech, a company that develops diabetes...

May 16, 2010
Reporters Notebook

Sandoz got its hands on a collection of generic drug candidates as it agreed to...

May 16, 2010
Reporters Notebook

Garden House Labs is making a big push against the Hispanic community with its natural...

May 9, 2010
Diabetes drug shown to improve A1c levels in trial

Patients treated with an investigational drug for Type 2 diabetes showed improved A1c levels in...

May 2, 2010
BioSante to re-initiate prostate cancer vaccine program

Drug maker BioSante Pharmaceuticals has restarted a development program for a prostate cancer vaccine, the...

April 18, 2010
Break away from outbreaks

Merix Pharmaceutical unveiled its new Fast-Results! genital herpes treatment March 1. The only over-the-counter treatment...

BARRINGTON, Ill. —Merix Pharmaceutical unveiled its new Fast-Results! genital herpes treatment March 1. The only over-the-counter treatment for genital herpes, Fast-Results! answers an unmet need of people who suffer painful symptoms associated with genital herpes outbreaks, and it can be used in conjunction with a prescription therapy for genital herpes.

March 25, 2010
Oramed completes mid-stage trial of Type 2 diabetes drug

Oramed Pharmaceuticals has finished a mid-stage clinical trial of a pill-based treatment for Type 2...

March 22, 2010
Merck KGaA suspends cancer vaccine trial

A mid-stage clinical trial program to investigate a Merck KGaA cancer vaccine has been put...

March 18, 2010
Citing potential problems, FDA declines to approve A.P. Pharma drug

The Food and Drug Administration raised a number of concerns that it said precluded the...

March 15, 2010
Teva seeks to market Shire's ADHD drug

Teva is hoping to get a generic drug for treating attention deficit hyperactivity disorder into...

March 11, 2010
Merix unveils new over-the-counter genital herpes treatment

Merix Pharmaceutical unveiled its new Fast-Results! genital herpes treatment this month while attending the ECRM...

BARRINGTON, Ill. Merix Pharmaceutical unveiled its new Fast-Results! genital herpes treatment this month while attending the ECRM Cough, Cold and Allergy conference in Dallas.

The only OTC treatment for genital herpes, Fast-Results! answers an unmet need of people who suffer painful symptoms associated with genital herpes outbreaks. Designed to be used in conjunction with prescription medication, Fast-Results! also brings needed treatment to consumers who cannot afford prescription medication.

March 11, 2010
Pfizer says clinical trials for Sutent did not meet expectations; halts additional cancer treatment study

Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...

March 7, 2010
Clinical study: Pfizer-Bristol anticoagulant more effective than competitior

A pill-based anticoagulant drug under development by Pfizer and Bristol-Myers Squibb worked better in reducing...

February 23, 2010
FDA committee recommends approval of Xifaxan

A Food and Drug Administration committee has recommended approval for a drug to treat a...

February 23, 2010
Prevnar 13 receives FDA approval

The Food and Drug Administration has approved a vaccine for preventing pneumococcal disease in children,...

February 21, 2010
FDA approves Menveo

Novartis has received Food and Drug Administration approval for a vaccine for meningococcal disease, the...

CAMBRIDGE, Mass. Novartis has received Food and Drug Administration approval for a vaccine for meningococcal disease, the Swiss drug maker’s vaccines division announced Monday.

The FDA approved Menveo (meningococcal [groups A, C, Y and W-135] oligosaccharide diphtheria CRM197) to prevent meningococcal disease caused by Neisseria meningitidis bacteria.

 

February 21, 2010
FDA approves Parkinson's disease treatment

The Food and Drug Administration has approved a new treatment for Parkinson’s disease made by...

February 17, 2010
GSK, XenoPort receive complete response letter for RLS drug

The Food and Drug Administration has declined to approve a drug used to treat restless...

February 16, 2010
Drug makers sign agreement to develop rheumatoid arthritis drug

Anglo-Swedish drug maker AstraZeneca and American drug maker Rigel Pharmaceuticals have signed a global licensing...

February 10, 2010
Roche to expand diabetes pipeline

Diabetes patients may soon find themselves with an expanded range of treatment options....

February 9, 2010
Biovail, Alexza develop inhaled mental health treatment

An inhaled mental health drug could appear on the market in the near future under...

February 3, 2010
Labopharm's Oleptro approved by FDA

The Food and Drug Administration has approved a new drug for treating major depressive disorder...

January 27, 2010
FDA approves labeling update for HIV drug

Tibotec Therapeutics announced Thursday that the Food and Drug Administration has approved a labeling update...